SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.

SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.

Item
http://www.wikidata.org/entity/Q27851475
Genetic determinants and potential therapeutic targets for pancreatic adenocarcinomaRhoT1 and Smad4 are correlated with lymph node metastasis and overall survival in pancreatic cancerRecent progress in pancreatic cancerPancreatic Cancer from Molecular Pathways to Treatment OpinionSurgical and molecular pathology of pancreatic neoplasmsChromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomasMolecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic CancerFAK and paxillin, two potential targets in pancreatic cancerMechanistic basis and clinical relevance of the role of transforming growth factor-β in cancerMolecular targets for the treatment of pancreatic cancer: Clinical and experimental studiesOrchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer: Normalization, Not DestructionAdvances in systemic therapy for advanced pancreatobiliary malignanciesMolecular landscape of pancreatic cancer: implications for current clinical trialsEvolution and dynamics of pancreatic cancer progressionCIViC databaseGenetic factors affecting patient responses to pancreatic cancer treatmentNew challenges in perioperative management of pancreatic cancerUpdate on the management of pancreatic cancer: surgery is not enoughAcquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound.Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinibReporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.Genetically defined subsets of human pancreatic cancer show unique in vitro chemosensitivity.Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression.SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cellsThe DPC4/SMAD4 genetic status determines recurrence patterns and treatment outcomes in resected pancreatic ductal adenocarcinoma: A prospective cohort study.Pathology and molecular genetics of pancreatic neoplasms.Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.The effect of transforming growth factor-beta1 on nasopharyngeal carcinoma cells: insensitive to cell growth but functional to TGF-beta/Smad pathwayMolecular signatures of pancreatic cancer.Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas.Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer.Cyclooxygenase- and lipoxygenase-mediated DNA damage.Translational assessment of mitochondrial dysfunction of pancreatic cancer from in vitro gene microarray and animal efficacy studies, to early clinical studies, via the novel tumor-specific anti-mitochondrial agent, CPI-613.Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project.Molecular characteristics of pancreatic ductal adenocarcinomaTumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomasLow expression of the E3 ubiquitin ligase CBL confers chemoresistance in human pancreatic cancer and is targeted by epidermal growth factor receptor inhibition.Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas.Genomic landscapes of pancreatic neoplasia.
P2860
Q21129230-0682DB72-297B-457E-A151-F90C0CBF905FQ21134105-DD08C2DE-9256-4164-80AD-130620959FB1Q24626346-80EF9605-4900-49BC-BD73-6A820C40DEC6Q26743482-A1920301-60F8-4D4A-A5F8-F129A45EE5D0Q26748615-D72C9C59-7B0C-4D71-8305-C8BEB50B20A8Q26751724-50C34B90-EFF6-421F-A308-294F0F4EEEA9Q26765241-90099CAC-048F-4768-ACA6-19F726858D8EQ26765360-421F4A01-17B9-457D-BB92-476537C121AEQ26771386-46C53C07-0351-410F-84EB-57B638236747Q26774636-E6297BFC-C71A-4B32-8802-295FA1116254Q26801834-378D9EEB-420E-4A19-BDB9-952F8AFA41B9Q26822703-08F6B1B7-6344-45DC-B730-8037BDB9D1AFQ26824528-07B0A792-CE69-4EE7-9A0C-BFE544E2013BQ26849671-00CF86DC-522F-46B3-9A41-E5F7D3044DDEQ27612411-02D6304F-5706-48A0-86F4-EDC6A29D3369Q28075293-D276E06F-5D54-4B62-978A-19D5DD4BB3F2Q28082422-194D6D2F-21EE-4338-AD92-EF2C3473A71EQ28087060-83354325-0719-4456-93E7-E1C92EB1BA03Q30376511-605697D2-C04F-47D9-A38B-CEFFF51BA4A9Q30422319-27DCCA34-6468-4B8D-86D5-A5EE0D7A1CC6Q30514241-55DF83DA-7C94-4947-997A-7D89551EBDEFQ30528894-58182148-63C6-466C-87DF-BDBA93125E31Q30754497-12898762-651B-4193-AB22-B663933094FFQ33556577-D7BAF8CA-C8A4-4E87-B22B-2C350BA08E7FQ33566753-627E7EDE-0D5D-451F-9B0B-CB6CDB495BC4Q33581119-4B2AB737-DBCE-42EA-8D5A-DE7B951A6EB1Q33624574-A50EB62B-6FD9-4470-AE35-F613BECEFE10Q33833162-3CCA6BC6-D161-467F-93D9-D25D9469BD68Q33918801-375E0DBC-ABD0-414A-A3F3-593EB2D18D9AQ34008627-06B83955-ABE2-49FC-B00B-EB860939C443Q34177065-50A5395F-98ED-4FF4-9D03-7C03CDA1BA22Q34225293-39B84FA6-D462-4CEC-A050-0F42B31A70E9Q34385135-4D9C44B9-B343-4877-9B9C-C0B684A18DB6Q34630956-24EFA37F-C75F-43E6-A754-CB361A237D59Q34745252-C9C7EB78-EC83-4C5B-8612-C40EEEEDD1F4Q34806852-17A2884B-C1A6-457C-AA73-5A8F2095C564Q34861855-56485A03-EC7B-47F4-8887-52F10687F081Q35131817-B3B91FD7-32AD-475B-B384-91BDAE568A3DQ35161198-1653159A-43CE-4E6D-B9B2-C042D778A7D7Q35170720-27DF876D-3247-4541-A752-DEDBF3E3D745
P2860

SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.

Item
http://www.wikidata.org/entity/Q27851475
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.
@ast
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.
@en
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.
@nl
type
label
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.
@ast
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.
@en
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.
@nl
altLabel
SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer
@en
prefLabel
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.
@ast
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.
@en
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P356
P407
P433
P478
P50
P577
P698
P932
P3181
P356
P1433
P1476
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.
@en
P2093
P2860
P304
P31
P3181
P356
10.1158/1078-0432.CCR-09-0227
P407
P433
P478
P50
P577
P698
P932